The present invention relates to novel GPR 119 actives of formula (I), their tautomeric forms, stereoisomers thereof, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, Methods for their preparation, intermediates included in their preparations and the use of such compounds in medicaments.
展开▼
